1. Home
  2. PRTA vs SPIR Comparison

PRTA vs SPIR Comparison

Compare PRTA & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • SPIR
  • Stock Information
  • Founded
  • PRTA 2012
  • SPIR 2012
  • Country
  • PRTA Ireland
  • SPIR United States
  • Employees
  • PRTA N/A
  • SPIR 447
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • SPIR Telecommunications Equipment
  • Sector
  • PRTA Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • PRTA 346.4M
  • SPIR 363.0M
  • IPO Year
  • PRTA N/A
  • SPIR N/A
  • Fundamental
  • Price
  • PRTA $6.29
  • SPIR $12.23
  • Analyst Decision
  • PRTA Buy
  • SPIR Strong Buy
  • Analyst Count
  • PRTA 9
  • SPIR 5
  • Target Price
  • PRTA $27.67
  • SPIR $16.75
  • AVG Volume (30 Days)
  • PRTA 1.3M
  • SPIR 641.8K
  • Earning Date
  • PRTA 08-07-2025
  • SPIR 08-13-2025
  • Dividend Yield
  • PRTA N/A
  • SPIR N/A
  • EPS Growth
  • PRTA N/A
  • SPIR N/A
  • EPS
  • PRTA N/A
  • SPIR N/A
  • Revenue
  • PRTA $137,935,000.00
  • SPIR $99,502,000.00
  • Revenue This Year
  • PRTA N/A
  • SPIR N/A
  • Revenue Next Year
  • PRTA $122.02
  • SPIR $5.92
  • P/E Ratio
  • PRTA N/A
  • SPIR N/A
  • Revenue Growth
  • PRTA 54.55
  • SPIR N/A
  • 52 Week Low
  • PRTA $4.32
  • SPIR $6.26
  • 52 Week High
  • PRTA $25.42
  • SPIR $21.43
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 56.80
  • SPIR 57.96
  • Support Level
  • PRTA $6.16
  • SPIR $10.64
  • Resistance Level
  • PRTA $6.60
  • SPIR $12.86
  • Average True Range (ATR)
  • PRTA 0.27
  • SPIR 0.69
  • MACD
  • PRTA 0.04
  • SPIR 0.03
  • Stochastic Oscillator
  • PRTA 67.90
  • SPIR 71.62

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: